Violich Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.39M Sell
9,350
-400
-4% -$137K 0.37% 39
2026
Q1
$3.43M Sell
9,750
-500
-5% -$178K 0.4% 39
2025
Q4
$3.35M Sell
10,250
-1,150
-10% -$365K 0.37% 42
2025
Q3
$3.22M Sell
11,400
-200
-2% -$58K 0.38% 41
2025
Q2
$3.24M Hold
11,600
0.46% 40
2025
Q1
$3.61M Sell
11,600
-180
-2% -$53.2K 0.49% 37
2024
Q4
$3.07M Sell
11,780
-250
-2% -$74.2K 0.4% 37
2024
Q3
$3.88M Hold
12,030
0.5% 34
2024
Q2
$3.76M Hold
12,030
0.51% 34
2024
Q1
$3.42M Buy
12,030
+250
+2% +$73.2K 0.49% 35
2023
Q4
$3.39M Sell
11,780
-2,500
-18% -$681K 0.55% 33
2023
Q3
$3.84M Hold
14,280
0.65% 33
2023
Q2
$3.17M Hold
14,280
0.51% 36
2023
Q1
$3.45M Hold
14,280
0.59% 34
2022
Q4
$3.75M Sell
14,280
-300
-2% -$80.4K 0.67% 33
2022
Q3
$3.29M Sell
14,580
-450
-3% -$109K 0.62% 34
2022
Q2
$3.66M Sell
15,030
-3,000
-17% -$735K 0.64% 35
2022
Q1
$4.36M Sell
18,030
-60
-0.3% -$13.8K 0.64% 35
2021
Q4
$4.07M Sell
18,090
-2,640
-13% -$557K 0.58% 36
2021
Q3
$4.41M Sell
20,730
-100
-0.5% -$23K 0.71% 34
2021
Q2
$5.08M Sell
20,830
-70
-0.3% -$17.2K 0.85% 30
2021
Q1
$5.2M Sell
20,900
-350
-2% -$83.5K 0.94% 28
2020
Q4
$4.89M Hold
21,250
0.94% 28
2020
Q3
$5.4M Sell
21,250
-200
-0.9% -$49.5K 1.14% 26
2020
Q2
$5.06M Sell
21,450
-4,750
-18% -$1.08M 1.11% 26
2020
Q1
$5.31M Hold
26,200
1.42% 20
2019
Q4
$6.32M Sell
26,200
-100
-0.4% -$22K 1.38% 23
2019
Q3
$5.09M Sell
26,300
-2,104
-7% -$404K 1.22% 24
2019
Q2
$5.23M Sell
28,404
-450
-2% -$80.6K 1.29% 24
2019
Q1
$5.48M Sell
28,854
-100
-0.3% -$19.1K 1.39% 22
2018
Q4
$5.64M Sell
28,954
-150
-0.5% -$29.3K 1.6% 21
2018
Q3
$6.03M Sell
29,104
-25
-0.1% -$4.93K 1.38% 26
2018
Q2
$5.38M Sell
29,129
-135
-0.5% -$23.9K 1.35% 24
2018
Q1
$4.99M Hold
29,264
1.34% 25
2017
Q4
$5.09M Sell
29,264
-260
-0.9% -$46K 1.3% 27
2017
Q3
$5.5M Sell
29,524
-151
-0.5% -$26.8K 1.5% 24
2017
Q2
$5.11M Hold
29,675
1.49% 25
2017
Q1
$4.87M Hold
29,675
1.47% 27
2016
Q4
$4.97M Sell
29,675
-545
-2% -$82K 1.53% 26
2016
Q3
$5.04M Sell
30,220
-250
-0.8% -$42.3K 1.77% 23
2016
Q2
$4.64M Hold
30,470
1.46% 23
2016
Q1
$4.57M Sell
30,470
-500
-2% -$74.3K 1.47% 24
2015
Q4
$5.03M Sell
30,970
-1,300
-4% -$204K 1.67% 19
2015
Q3
$4.46M Hold
32,270
1.56% 17
2015
Q2
$4.95M Hold
32,270
1.62% 17
2015
Q1
$5.16M Sell
32,270
-670
-2% -$106K 1.68% 16
2014
Q4
$5.25M Sell
32,940
-100
-0.3% -$15.6K 1.67% 16
2014
Q3
$4.64M Hold
33,040
1.51% 22
2014
Q2
$3.91M Hold
33,040
1.31% 26
2014
Q1
$4.08M Sell
33,040
-50
-0.2% -$6.06K 1.42% 24
2013
Q4
$3.77M Buy
33,090
+200
+0.6% +$22.8K 1.35% 26
2013
Q3
$3.68M Sell
32,890
-150
-0.5% -$16.3K 1.44% 23
2013
Q2
$3.26M Buy
+33,040
New +$3.43M 1.32% 24

Other funds holding AMGN

Violich Capital Management's AMGN Position: Q2 2026 in Review

Violich Capital Management reduced its Amgen (AMGN) stake by 4.1% in Q2 2026, selling an estimated $137K and leaving 9,350 shares worth $3.39M. The position accounts for 0.37% of the portfolio, ranked #39.

Violich Capital Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.32M in Q4 2019. 1,323 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Violich Capital Management held 9,350 shares of Amgen worth $3.39M as of Q2 2026.
  • Violich Capital Management sold 400 Amgen shares in Q2 2026, an estimated $137K.
  • Amgen made up 0.37% of Violich Capital Management's portfolio in Q2 2026, its #39 holding.
  • Violich Capital Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Violich Capital Management's Amgen position peaked at $6.32M in Q4 2019.
  • 1,323 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Violich Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.